Repurposing CD8 + T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?

Authors :: Gujar S
Pol JG
Kim Y
Kroemer G
Source :: Oncoimmunology [Oncoimmunology] 2020 Jul 16; Vol. 9 (1), pp. 1794424. Date of Electronic Publication: 2020 Jul 16.
Publication Year :: 2020
Abstract: The COVID-19 pandemic has afflicted most countries on the planet. As a result, immunity against SARS-CoV-2, induced via natural infections or imminent vaccinations, is expected to develop in a large fraction of the global population. Here, we propose to exploit SARS-CoV-2-specific CD8 <superscript>+</superscript> T cells for cancer immunotherapy strategies.<br /> (© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.)

Subjects :: Antibodies, Viral immunology
Antibodies, Viral metabolism
CD8-Positive T-Lymphocytes immunology
CD8-Positive T-Lymphocytes metabolism
COVID-19 blood
COVID-19 epidemiology
COVID-19 prevention & control
COVID-19 Vaccines administration & dosage
Host Microbial Interactions immunology
Humans
Immunologic Memory
Neoplasms immunology
Pandemics
CD8-Positive T-Lymphocytes transplantation
COVID-19 immunology
Immunotherapy methods
Neoplasms therapy
SARS-CoV-2 immunology

Full Text Access

Tools